Valerio Therapeutics Société anonyme

ENXTPA:ALVIO Stock Report

Market Cap: €16.9m

Valerio Therapeutics Société anonyme Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ALVIO?
Owner TypeNumber of SharesOwnership Percentage
Institutions505,4170.328%
Public Companies17,857,14311.6%
Private Companies22,096,08214.3%
VC/PE Firms44,083,33828.6%
General Public69,535,13345.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 38.9%.


Top Shareholders

Top 6 shareholders own 54.87% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
28.6%
Artal Group S.A.
44,083,338€4.8m0%0.16%
14.3%
Financiére de la Montagne
22,096,082€2.4m0%no data
11.6%
Agenus Inc.
17,857,143€2.0m0%no data
0.27%
Aviva Investors Global Services Ltd.
411,195€45.2k-0.21%no data
0.043%
Generali Asset Management SGR SpA
65,625€7.2k0%no data
0.019%
BFT Investment Managers
28,597€3.1k0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.